Deciphering Biological Complexity

Michael’s talk will focus on 10x Genomics's newest technologies to deeply characterize biological samples at the individual cell level. Such single cell and spatial technologies have the power to unlock discoveries in biomedical research and ultimately directly impact human health. Further work on these core technologies will enable advances in fields such as oncology, neuroscience and immunology, with applications to infectious disease such as COVID-19 and immune system steering to fight cancer.

This Hertz Foundation Innovation Hour will take place live on Wednesday, January 24, 2024, from 12:00–1:00 p.m. Pacific / 3:00–4:00 p.m. Eastern, using the Zoom video conference platform.

Registration for this event is closed.

Michael Schnall-Levin is the Chief Technology Officer and Founding Scientist at 10x Genomics, where he has been since the company's inception in 2012. In that role, he is responsible for 10x's technology strategy, including setting the internal technology and product roadmap as well as leading external technology evaluation resulting in licensing and M&A. He also leads the research and development groups at 10x that develop new products in single cell and spatial analysis.

Before joining 10x Genomics, Michael was a NSF postdoctoral fellow with Eric Lander at the Broad Institute, where he worked on developing novel applications of DNA sequencing technologies. Prior to that, Michael worked at Foundation Medicine, where he developed some of the early algorithms to accurately detect mutations in patient tumor samples. Michael earned his Ph.D in Mathematics from MIT with Bonnie Berger, where he was both a Hertz fellow and NDSEG fellow, and his B.A. in Physics from Harvard College.